Target intelligence / Profile preview

NAD(P)H quinone oxidoreductase 2 (NQO2)

Target
NQO2
Molecular classification
Enzyme, NAD(P)H dehydrogenase (quinone), Flavoprotein
01

Overview

NAD(P)H quinone oxidoreductase 2 (NQO2), also known as QR2, is a cytosolic flavoprotein enzyme that catalyzes the two-electron reduction of quinones to hydroquinones using dihydronicotinamide riboside (NRH) as an electron donor. It plays roles in phase II detoxification pathways and has been associated with neurodegenerative diseases and several cancers.

Other names
QR2NMOR2NRH:quinone oxidoreductase 2Ribosyldihydronicotinamide dehydrogenase [quinone]
02

Mechanism of action

Catalyzes the two-electron reduction of quinones to hydroquinones using dihydronicotinamide riboside (NRH) as an electron donor.

03

Biological functions

Detoxification of xenobiotics/oxidative stress protectionMemoryBiosynthesis including vitamin K-dependent carboxylationElectron carrier activityDihydronicotinamide riboside quinone reductase activityMetal ion binding
04

Disease associations

Neurodegenerative diseasesCancerBreast cancer
05

Interacting drugs

Resveratrol

1 more in the full profile.

Beyond the preview

Go deeper on NAD(P)H quinone oxidoreductase 2 (NQO2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAD(P)H quinone oxidoreductase 2 (NQO2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call